295 related articles for article (PubMed ID: 31367254)
1. Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis.
Tang TT; Lv LL; Wang B; Cao JY; Feng Y; Li ZL; Wu M; Wang FM; Wen Y; Zhou LT; Ni HF; Chen PS; Gu N; Crowley SD; Liu BC
Theranostics; 2019; 9(16):4740-4755. PubMed ID: 31367254
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment.
Sang X; Wang Y; Xue Z; Qi D; Fan G; Tian F; Zhu Y; Yang J
Front Immunol; 2021; 12():613907. PubMed ID: 33679754
[TBL] [Abstract][Full Text] [Related]
3. Visualized podocyte-targeting and focused ultrasound responsive glucocorticoid nano-delivery system against immune-associated nephropathy without glucocorticoid side effect.
Fan K; Zeng L; Guo J; Xie S; Yu Y; Chen J; Cao J; Xiang Q; Zhang S; Luo Y; Deng Q; Zhou Q; Zhao Y; Hao L; Wang Z; Zhong L
Theranostics; 2021; 11(6):2670-2690. PubMed ID: 33456566
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism.
Ikezumi Y; Atkins RC; Nikolic-Paterson DJ
J Am Soc Nephrol; 2003 Apr; 14(4):888-98. PubMed ID: 12660323
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor 2 Release by Macrophages: An Anti-inflammatory Program Induced by Glucocorticoids and Lipopolysaccharide.
Hoppstädter J; Dembek A; Linnenberger R; Dahlem C; Barghash A; Fecher-Trost C; Fuhrmann G; Koch M; Kraegeloh A; Huwer H; Kiemer AK
Front Immunol; 2019; 10():1634. PubMed ID: 31396208
[TBL] [Abstract][Full Text] [Related]
6. Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors.
Wang XQ; Zhou X; Zhou Y; Rong L; Gao L; Xu W
Respirology; 2008 Nov; 13(6):772-80. PubMed ID: 18657064
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids.
Liu H; Liu D; Ji M; Xiao P; Qin Y; Zhao J; Wang N; Gou J; Yin T; He H; Chen G; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 622():121900. PubMed ID: 35690305
[TBL] [Abstract][Full Text] [Related]
8. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization.
Li Y; Liang Q; Zhou L; Cao Y; Yang J; Li J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():406-424. PubMed ID: 36055613
[TBL] [Abstract][Full Text] [Related]
9. Microvesicle-Mediated Communication Within the Alveolar Space: Mechanisms of Uptake by Epithelial Cells and Alveolar Macrophages.
Soni S; O'Dea KP; Abe E; Khamdan M; Shah SV; Sarathchandra P; Wilson MR; Takata M
Front Immunol; 2022; 13():853769. PubMed ID: 35572508
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-loaded Polymeric Nanoconstructs for Monitoring and Treating Inflammatory Bowel Disease.
Lee A; De Mei C; Fereira M; Marotta R; Yoon HY; Kim K; Kwon IC; Decuzzi P
Theranostics; 2017; 7(15):3653-3666. PubMed ID: 29109767
[TBL] [Abstract][Full Text] [Related]
11. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
[TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated dexamethasone attenuates ventilator-induced lung inflammation.
Hegeman MA; Cobelens PM; Kamps J; Hennus MP; Jansen NJ; Schultz MJ; van Vught AJ; Molema G; Heijnen CJ
Br J Pharmacol; 2011 Jul; 163(5):1048-58. PubMed ID: 21391981
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of radiation nephropathy in rats by postirradiation treatment with dexamethasone and/or captopril.
Geraci JP; Sun MC; Mariano MS
Radiat Res; 1995 Jul; 143(1):58-68. PubMed ID: 7597145
[TBL] [Abstract][Full Text] [Related]
14. A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis.
Yuan F; Tabor DE; Nelson RK; Yuan H; Zhang Y; Nuxoll J; Bynoté KK; Lele SM; Wang D; Gould KA
PLoS One; 2013; 8(11):e81483. PubMed ID: 24312306
[TBL] [Abstract][Full Text] [Related]
15. [The protective effect of different doses of dexamethasone on acute kidney injury induced by sepsis in mice].
Yang J; Wu DW; Tang LN; Lu HN; Zhang F; Guo HP; Hu Z; Huang SY
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):424-8. PubMed ID: 23834942
[TBL] [Abstract][Full Text] [Related]
16. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
Moonen L; Geryl H; D'Haese PC; Vervaet BA
BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids differentially regulate expression of duodenal and renal calbindin-D9k through glucocorticoid receptor-mediated pathway in mouse model.
Lee GS; Choi KC; Jeung EB
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E299-307. PubMed ID: 16219669
[TBL] [Abstract][Full Text] [Related]
19. Tandem Enzymatic Self-Assembly and Slow Release of Dexamethasone Enhances Its Antihepatic Fibrosis Effect.
Tang W; Zhao Z; Chong Y; Wu C; Liu Q; Yang J; Zhou R; Lian ZX; Liang G
ACS Nano; 2018 Oct; 12(10):9966-9973. PubMed ID: 30285414
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
Li Q; Chen C; Chen X; Han M; Li J
Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
